What's Hot
View all perspectives
Janet Pope Janetbirdope
1 year 4 months ago
#SLE #EULAR recommendations What is new - use LESS #glucocorticoids, aim for none or 5 mg/d or less, use #biologics early if needed to prevent damage, #lupus #nephritis consider less pulse dose if using, voclosporin vs Belimumab ? it depends @RheumNow #EULAR2023 https://t.co/Ylnnl3pHOK
Dr. Antoni Chan synovialjoints
1 year 4 months ago
Late Breaker - Cardiorespiratory fitness increased in patients with IJD after 12 weeks of supervised
HIIT and effect maintained at 6 months. No significant differences in pain and fatigue vs control. HIIT is a viable intervention Norden K Abst#LB0007 #EULAR2023 @RheumNow
Bella Mehta bella_mehta
1 year 4 months ago
Diagnostic delay in #lupus is really prevalent!
#EULAR2023 @RheumNow
20% with new lupus diagnosis are hospitalized!
20% diagnosis is delayed for more than 3 months! https://t.co/1vCcezBrQS
David Liew drdavidliew
1 year 4 months ago
2023 @eular_org recommendations for LVV imaging
interestingly, the key changes vs 2018 are about PET/CT:
- can consider PET/CT for cranial GCA diagnosis
- PET/CT (alt MRI) can be used for monitoring - more for when you lose ESR/CRP because of IL-6i
#EULAR2023 @RheumNow https://t.co/2DC37CM6gA
Bella Mehta bella_mehta
1 year 4 months ago
Meds in #lupus at #EULAR2023 recs
- HCQ first line therapy. Target dose remains the same. Some discussion on monitoring levels if possible
- MAIN CHANGE - Glucocorticoids to be minimized (only use for bridging). Nephrologists more so in favor of steroid free remission @RheumNow https://t.co/d8WnUOgrwq
David Liew drdavidliew
1 year 4 months ago
Scleroderma therapeutics: we’re actually getting some choices!
Christian Dejaco #EULAR2023 @RheumNow https://t.co/sW2FBY0RqS
Bella Mehta bella_mehta
1 year 4 months ago
JaL1/TYK2 inhibitor vs Tofacitinib in #RA at #EULAR2023 phase 2. @RheumNow https://t.co/0F3JQ9dVMA
Bella Mehta bella_mehta
1 year 4 months ago
Abstracts talking about #RA and JAKs and Biologic comparisons
Huge number of pts to analyze this aftrr the initial NEJM study. Abstract summary pics below
@RheumNow https://t.co/jl5S4fLq19
Bella Mehta bella_mehta
1 year 4 months ago
Abatacept in pts at risk of #RA data from clinical trial.
213 pts, 31 centers.
Pts with multiple autoantibodies improved the most with abatacept.
@rheumnow #EULAR2023 https://t.co/c82jx0cAEq
Bella Mehta bella_mehta
1 year 4 months ago
Central sensitization of neuropathic pain in #PsA - patient reported outcomes.
114 pts. And 22 percent with fibromyalgia
Pts with neuropathic pain didnt reach low disease activity or remission.
@RheumNow #EULAR2023 highlights! https://t.co/Gxkcrruamp
Bella Mehta bella_mehta
1 year 4 months ago
MmF and Tacrolimus both work in systemic sclerosis with ILD. @RheumNow #EULAR2023 https://t.co/Ro6AjP3nij
Aurelie Najm AurelieRheumo
1 year 4 months ago
2023 update @EULAR recommendations imaging in GCA
What's new:
1. US = first line imaging test
2. Axillary arteries should be included in standard examination
3. Alternative imaging FDG-PET or MRI
4. Takayasu: MRI preferred CT or FDG-PET alternatives
@Rheumnow #EULAR23 LB0008 https://t.co/rGPfOPX1gI
Bella Mehta bella_mehta
1 year 4 months ago
CAR-T cells in refarctory SLE- long term data presented #EULAR2023
Pts did well except some mild cytopenias. Pts remained in remission.
Maybe a good option in the near future for refractory pts!
@RheumNow https://t.co/NWoFBipOiQ
Md Yuzaiful Md Yusof Yuz6Yusof
1 year 4 months ago
#EULAR2023 Clinical Highlights. CTD: OP0240 Open label study (N=26) showed stabilisation/improvement in FVC in patients with #ILD treated either Tacrolimus vs MMF. No efficacy difference between both therapies @RheumNow https://t.co/d3rCzNgYHK
Bella Mehta bella_mehta
1 year 4 months ago
Microvascular visualization in Behcet's disease by ultrasound. Maybe really useful in cases which are difficult to diagnose and may not need biopsies in some pts.
#EULAR2023 @RheumNow https://t.co/PbC3tCe7v6
Poster Hall